Max Bittrich
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
Papers in
- Hematology 16
- Multiple Myeloma Research and Treatments 14
- Hematopoietic Stem Cell Transplantation 2
- Acute Myeloid Leukemia Research 1
- Oncology 10
- Cancer Treatment and Pharmacology 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Antonio Giovanni Solimando (7 shared papers)Hermann Einsele (11 shared papers)Andreas Rosenwald (2 shared papers)Markus Krebs (4 shared papers)Andreas Beilhack (4 shared papers)K. Martin Kortüm (8 shared papers)Stefan Knop (6 shared papers)Thorsten Stühmer (1 shared paper)
In The Last Decade
Max Bittrich
20 papers receiving 238 citations
Peers
Comparison fields: 5 of 47
- Hematology 109
- Oncology 130
- Immunology 57
- Immunology and Allergy 12
- Cancer Research 28
Countries citing papers authored by Max Bittrich
This map shows the geographic impact of Max Bittrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Bittrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Bittrich more than expected).
Fields of papers citing papers by Max Bittrich
This network shows the impact of papers produced by Max Bittrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Bittrich. The network helps show where Max Bittrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Bittrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 53 | |
| 2 | 2015 | 33 | |
| 3 | 2021 | 30 | |
| 4 | 2020 | 20 | |
| 5 | 2018 | 14 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 10 | |
| 8 | 2018 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2019 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2018 | 1 |
About Max Bittrich
Max Bittrich is a scholar working on Hematology, Oncology, Molecular Biology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 243 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (7 papers), Cancer Treatment and Pharmacology (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Cancer Genomics and Diagnostics (2 papers), Peptidase Inhibition and Analysis (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (109 citations), Oncology (130 citations), Immunology (57 citations), Immunology and Allergy (12 citations) and Cancer Research (28 citations). Max Bittrich has collaborated with scholars based in Germany, Italy and Spain. Frequent co-authors include Antonio Giovanni Solimando, Hermann Einsele, Andreas Rosenwald, Markus Krebs, Andreas Beilhack, K. Martin Kortüm, Stefan Knop, Thorsten Stühmer, Svenja Meierjohann and Vanessa Desantis. Their work appears in journals such as Blood, Journal of Cancer Research and Clinical Oncology, International Journal of Molecular Sciences, Frontiers in Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.